Delivery Order SPE2DR25D1110-SPE2DR26F13LT
- Not listed
- The Defense Logistics Agency awarded a $5,607.96 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drops (3 milliliter units) on December 11, 2025, with a completion date of December 12, 2025. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $19,377.99 to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on December 17, 2025, with an ultimate completion date of December 18, 2025. The contract employs firm fixed price terms and carries no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,415.89 to AmerisourceBergen Drug Corp for supply of Miebo 100% eye drops (3ml) on October 29, 2025, with completion targeted for October 30, 2025. The contract is a firm fixed price delivery order with no set-aside designation, performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded a delivery order valued at $16,904.27 to AmerisourceBergen Drug Corp for Miebo 100% eye drop supplies (3ml) on December 16, 2025, with an ultimate completion date of December 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $3,024.73 to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on December 22, 2025, with an ultimate completion date of December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $6,059.49 to AmerisourceBergen Drug Corp for Miebo 100% Eye Drop 3ML on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a $11,022.45 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drops (3ml) on December 18, 2025, with completion scheduled for December 19, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $1,152.56 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Miebo 100% eye drops (3ml), with completion targeted for November 26, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in Conshohocken, PA. This...
- The Defense Logistics Agency awarded a $11,297.46 delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Miebo 100% eye drop (3ml units). The contract, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by June 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,194.80 to AmerisourceBergen Drug Corp for MIEBO 100% eye drops (3ml) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price contract represents a non-competitive set-aside award and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- SPE2DR25D1110Indefinite Delivery Contract
- SPE2DR25D1110-SPE2DR26F13LTDelivery Order
The Defense Logistics Agency awarded a $1,256.89 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on January 2, 2026, with completion targeted for January 5, 2026. The contract utilizes firm fixed pricing with no set-aside designation, indicating open competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceuticals and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The DLA contract vehicle provides flexible procurement capabilities for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with the agency planning future Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/1/26 |